Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 29, 2023 08:30 ET | Source: CytoSorbents

Landmark Publication Underscores Robust Ability of CytoSorb to Reduce Cytokine Storm during Systemic Hyperinflammation

PRINCETON, N.J., March 29, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
March 22, 2023 08:09 ET | Source: CytoSorbents

CytoSorbents Highlights New Clinical Data from Current Studies at the Live 42nd International Symposium on Intensive Care & Emergency Medicine (ISICEM)

PRINCETON, N.J., March 22, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
March 14, 2023 07:00 ET | Source: CytoSorbents

CytoSorbents Comments on Bank Exposure and Diversified Cash Position

PRINCETON, N.J., March 14, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
March 09, 2023 16:15 ET | Source: CytoSorbents

CytoSorbents Reports Fourth Quarter and Full Year 2022 Results

Pivotal U.S. and Canada STAR-T Trial enrollment passes halfway mark. Positive sales momentum from Q4 2022 continues in Q1 2023 to date, with expectation of sales growth in 2023 PRINCETON, N.J., March...
March 07, 2023 07:00 ET | Source: CytoSorbents

New European “Guidelines for the Management of Severe Perioperative Bleeding” Consider Hemoadsorption for the First-Time

PRINCETON, N.J., March 07, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
July 08, 2013 09:00 ET | Source: CytoSorbents

CytoSorbents Appoints Dr. Rainer Kosanke as European Director of Scientific Affairs

MONMOUTH JUNCTION, N.J., July 8, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO), a critical care focused company commercializing its European Union approved CytoSorb® blood filter...
June 27, 2013 09:00 ET | Source: CytoSorbents

CytoSorbents Announces Start of $1M US Army Phase II SBIR Contract and Closing of Additional Funding

MONMOUTH JUNCTION, N.J., June 27, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB: CTSO), a critical care focused company commercializing its European Union approved CytoSorb®...
June 17, 2013 08:00 ET | Source: CytoSorbents

CytoSorbents Announces FDA Approved US Air Force Funded Human Trauma Pilot Study for Rhabdomyolysis

MONMOUTH JUNCTION, N.J., June 17, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO), a critical care focused company using blood purification to treat life-threatening illnesses in the...
June 13, 2013 09:00 ET | Source: CytoSorbents

CytoSorbents Enters Into Exclusive Distribution Agreement for CytoSorb(R) With Hitit Medical Systems in Turkey

MONMOUTH JUNCTION, N.J., June 13, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO), a critical care focused therapeutic device company using blood purification to treat life-threatening...
May 16, 2013 07:00 ET | Source: CytoSorbents

CytoSorbents Reports 2013 First Quarter Financial Results

MONMOUTH JUNCTION, N.J., May 16, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO) is a critical care focused company using blood purification to treat life-threatening illnesses in the...